Long-term survival with primary glioblastoma multiforme: A clinical study in bulgarian patients

Case Reports in Oncology

Volumn 4, Issue 1, 2011, Pages 1-11

  Naydenov, E ^a   Tzekov, C ^a   Minkin, K ^a   Nachev, S ^a   Romansky, K ^a   Bussarsky, V ^a  

^a UNIVERSITY HOSPITAL ST IVAN RILSKI   (Bulgaria)

Author keywords

Long term survival; Primary glioblastoma multiforme; Prognostic factors

Indexed keywords

TEMOZOLOMIDE;

ADULT; ARTICLE; BULGARIA; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HOMONYMOUS HEMIANOPIA; HUMAN; IMAGE ANALYSIS; INTRACRANIAL HYPERTENSION; KARNOFSKY PERFORMANCE STATUS; MALE; MEDICAL LITERATURE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL TIME;

EID: 79957605711     PISSN: None     EISSN: 16626575     Source Type: Journal    
DOI: 10.1159/000323432     Document Type: Article

References (35)

1. Adamson C, Kanu OO, Mehta AI, Di C, Lin N, Mattox AK, Bigner DD: Glioblastoma multiforme: a review of where we have been and where we are going. Expert Opin Investig Drugs 2009;18:1061-1083.
2. Kanu OO, Mehta A, Di C, Lin N, Bortoff K, Bigner DD, Yan H, Adamson DC: Glioblastoma multiforme: a review of therapeutic targets. Expert Opin Ther Targets 2009;13:701-718.
3. Smith JS, Jenkins RB: Genetic alterations in adult diffuse glioma: occurrence, significance, and prognostic implications. Front Biosci 2000;5:213-231.
4. Erpolat OP, Akmansu M, Goksel F, Bora H, Yaman E, Buyukberber S: Outcome of newly diagnosed glioblastoma patients treated by radiotherapy plus concomitant and adjuvant temozolomide: a long-term analysis. Tumori 2009;95:191-197.
5. Chandler KL, Prados MD, Malec M, Wilson CB: Long-term survival in patients with glioblastoma multiforme. Neurosurgery 1993;32:716-720. (Pubitemid 23134013)
6. Scott JN, Rewcastle NB, Brasher PM, Fulton D, MacKinnon JA, Hamilton M, Cairncross J, Forsyth P: Which glioblastoma multiforme patient will become a long-term survivor? A population-based study. Ann Neurol 1999;46:183-188. (Pubitemid 29382874)
7. Krex D, Klink B, Hartmann C, von Deimling SM, Sabel M, Steinbach JP, Heese O, Reifenberger G, Weller M, Schackert G: Long-term survival with glioblastoma multiforme. Brain 2007;130(Pt 10):2596-2606. (Pubitemid 47511715)
8. Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Patre PL, Burkhard C, Schuler D, Probst-Hensch NM, Maiorka PC, Baeza N, Pisani P, Yonekawa Y, Yasargil MG, Lutolf UM, Kleihues P: Genetic pathways to glioblastoma: a population-based study. Cancer Res 2004;64:6892-6899. (Pubitemid 39330996)
9. Filippini G, Falcone C, Boiardi A, Broggi G, Bruzzone MG, Caldiroli D, Farina R, Farinotti M, Fariselli L, Finocchiaro G, Giombini S, Pollo B, Savoiardo M, Solero CL, Valsecchi MG: Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma. Neuro Oncol 2008;10:79-87. (Pubitemid 351250903)
10. Sonoda Y, Kumabe T, Watanabe M, Nakazato Y, Inoue T, Kanamori M, Tominaga T: Long-term survivors of glioblastoma: clinical features and molecular analysis. Acta Neurochir (Wien) 2009;151:1349-1358.
11. Glas M, Happold C, Rieger J, Wiewrodt D, Bahr O, Steinbach JP, Wick W, Kortmann RD, Reifenberger G, Weller M, Herrlinger U: Long-term survival of patients with glioblastoma treated with radiotherapy and lomustine plus temozolomide. J Clin Oncol 2009;27:1257-1261.
12. Chandler KL, Prados MD, Malec M, Wilson CB: Long-term survival in patients with glioblastoma multiforme. Neurosurgery 1993;32:716-720. (Pubitemid 23134013)
13. Archibald YM, Lunn D, Ruttan LA, Macdonald DR, Del Maestro RF, Barr HW, Pexman JH, Fisher BJ, Gaspar LE, Cairncross JG: Cognitive functioning in long-term survivors of high-grade glioma. J Neurosurg 1994;80:247-253. (Pubitemid 24036495)
14. Morita M, Rosenblum MK, Bilsky MH, Fraser RA, Rosenfeld MR: Long-term survivors of glioblastoma multiforme: clinical and molecular characteristics. J Neuro Oncol 1996;27:259-266. (Pubitemid 26098125)
15. Burton EC, Lamborn KR, Feuerstein BG, Prados M, Scott J, Forsyth P, Passe S, Jenkins RB, Aldape KD: Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma. Cancer Res 2002;62:6205-6210. (Pubitemid 35244472)
16. Mc Lendon RE, Halperin EC: Is the long-term survival of patients with intracranial glioblastoma multiforme overstated? Cancer 2003;98:1745-1748. (Pubitemid 37238632)
17. Steinbach JP, Blaicher HP, Herrlinger U, Wick W, Nagele T, Meyermann R, Tatagiba M, Bamberg M, Dichgans J, Karnath HO, Weller M: Surviving glioblastoma for more than 5 years: the patient's perspective. Neurology 2006;66:239-242. (Pubitemid 43970162)
18. Nieder C, Astner ST, Molls M, Grosu AL: Analysis of long-term survivors of glioblastoma multiforme in a single institution with aggressive local retreatment protocol. Anticancer Res 2007;27:2993-2996. (Pubitemid 47228034)
19. Chaichana K, Parker S, Olivi A, Quinones-Hinojosa A: A proposed classification system that projects outcomes based on preoperative variables for adult patients with glioblastoma multiforme. J Neurosurg 2010;112:997-1004.
20. Shinojima N, Kochi M, Hamada J, Nakamura H, Yano S, Makino K, Tsuiki H, Tada K, Kuratsu J, Ishimaru Y, Ushio Y: The influence of sex and the presence of giant cells on postoperative long-term survival in adult patients with supratentorial glioblastoma multiforme. J Neurosurg 2004;101:219-226. (Pubitemid 38970996)
21. Scott JN, Rewcastle NB, Brasher PM, Fulton D, Hagen NA, MacKinnon JA, Sutherland G, Cairncross JG, Forsyth P: Long-term glioblastoma multiforme survivors: a population-based study. Can J Neurol Sci 1998;25:197-201. (Pubitemid 28368794)
22. Mineo JF, Quintin-Roue LB, Buburusan V, Besson G: Glioblastomas: clinical study and search for prognostic factors. Neurochirurgie 2002;48:500-509. (Pubitemid 36168973)
23. Simpson JR, Horton J, Scott C, Curran WJ, Rubin P, Fischbach J, Isaacson S, Rotman M, Asbell SO, Nelson JS: Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: Results of three consecutive radiation therapy oncology group (RTOG) clinical trials. Int J Radiat Oncol Biol Phys 1993;26:239-244. (Pubitemid 23156970)
24. Jeremic B, Milicic B, Grujicic D, Dagovic A, Aleksandrovic J, Nikolic N: Clinical prognostic factors in patients with malignant glioma treated with combined modality approach. Am J Clin Oncol 2004;27:195-204. (Pubitemid 38451483)
25. Kozak KR, Moody JS: Giant cell glioblastoma: a glioblastoma subtype with distinct epidemiology and superior prognosis. Neuro Oncol 2009;11:833-841.
26. Naydenov E, Bussarsky V, Nachev S, Hadjidekova S, Toncheva D: Long-term survival of a patient with giant cell glioblastoma: Case report and review of the literature. Case Rep Oncol 2009;2:103-110.
27. Deb P, Sharma MC, Mahapatra AK, Agarwal D, Sarkar C: Glioblastoma multiforme with long term survival. Neurol India 2005;53:329-332. (Pubitemid 41526848)
28. Sabel M, Reifenberger J, Weber RG, Reifenberger G, Schmitt HP: Long-term survival of a patient with giant cell glioblastoma. Case report. J Neurosurg 2001;94:605-611. (Pubitemid 32799654)
29. Sulman EP, Guerrero M, Aldape K: Beyond grade: molecular pathology of malignant gliomas. Semin Radiat Oncol 2009;19:142-149.
30. Burton EC, Lamborn KR, Forsyth P, Scott J, O'Campo J, UyeharaLock J, Prados M, Berger M, Passe S, Uhm J, O'Neill BP, Jenkins RB, Aldape KD: Aberrant p53, mdm2, and proliferation differ in glioblastomas from longterm compared with typical survivors. Clin Cancer Res 2002;8:180-187. (Pubitemid 34101475)
31. Korshunov A, Sycheva R, Golanov A: Genetically distinct and clinically relevant subtypes of glioblastoma defined by array-based comparative genomic hybridization (array-CGH). Acta Neuropathol 2006;111:465-474.
32. Carro MS, Lim WK, Alvarez MJ, Bollo RJ, Zhao X, Snyder EY, Sulman EP, Anne SL, Doetsch F, Colman H, Lasorella A, Aldape K, Califano A, Iavarone A: The transcriptional network for mesenchymal transformationof brain tumours. Nature 2010;463:318-325.
33. Minniti G, De Sanctis V, Muni R, Filippone F, Bozzao A, Valeriani M, Osti MF, De Paula U, Lanzetta G, Tombolini V, Maurizi Enrici R: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients. J Neurooncol 2008;88:97-103.
34. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352:987-996. (Pubitemid 40349501)
35. Hottinger AF, Yoon H, DeAngelis LM, Abrey LE: Neurological outcome of long-term glioblastoma survivors. J Neurooncol 2009;95:301-305.